GLP-1 composition for treating obesity and weight management

• 收藏
• 分享

专利权人:

Shanghai Benemae Pharmaceutical Corporation

发明人:

YU, Zhiwen,ZUO, Yajun,XIA, Jing,WANG, Shichuang,QIAN, Lifen

申请号：

AU2019229469

公开号：

AU2019229469A1

申请日:

2019.03.08

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Uses of a recombinant human GLP-1 peptide, the uses include preventing or treating obesity and/or over weight, and managing body weight. The therapeutically effective amount of the GLP-1 peptide is from about 0.11 mg/day to about 0.66 mg/day.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/